🇮🇳IN
Sign In
CO

COHANCE

NSE

Cohance Lifesciences Limited

₹481.35

+5.30(+1.11%)

Group Companies

Foreign Flows

sector level — not this stock
Healthcare sector+₹2,114 Crnet foreign buying
2026-09-01 to 2026-09-15

This is the flow into the whole Healthcare sector, not into COHANCE. We report it at the level it is measured — attributing a sector figure to one company would be inventing a number nobody published.

Supply Chain

suppliers and customers in the graph

Relationship Network

directors, institutions, group entities

Macro Sensitivity

rates, currency, commodities

Revenue by Segment

Business Group

Geographic Exposure

revenue, imports, currency

Scenario analysis

stated assumptions, shown workings

COHANCE exposure summary

Cohance Lifesciences Limited reports a single business segment, CONTRACT DEVELOPMENT AND MANUFACTURING. Cohance Lifesciences Limited is a constituent of 5 indices, with its largest weights in NIFTY Smallcap 100 (0.61%), S&P BSE 500 (0.04%), NIFTY 500 (0.04%).

Index memberships5

Investment in securities market are subject to market risks. Read all the related documents carefully before investing. Disclaimer